For example, TIM-3 mediates suppression of NK cells in chronic hepatitis B patients, while TIM-3 blockade results in increased NK cell cytotoxicity both in vitro and ex vivo (103). Here, HAVCR2 is linked to chronic hepatitis B virus infection.